Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort study.
Kwabena AsareYukteshwar SookrajhJohan van der MolenThokozani KhuboneLara LewisRichard J LessellsKogieleum NaidooPhelelani SosiboRosemary van HeerdenSharana MahomedJienchi DorwardPublished in: medRxiv : the preprint server for health sciences (2023)
Bill & Melinda Gates Foundation, Africa Oxford Initiative.